CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical pharmacology and therapy

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clpt.2006.08.011PMID 17112802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy

  2006cited by this paper
• Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence

  2005cited by this paper
• A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.

  2005influential reference
• Three haplotypes associated with CYP2A6 phenotypes in Caucasians

  2005cited by this paper
• Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method.

  2005cited by this paper
• Metabolism and Disposition Kinetics of Nicotine

  2005cited by this paper
• Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation.

  2005cited by this paper
• Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence

  2005cited by this paper
• Tests for Establishing Compatibility of an Observed Genotype Distribution with Hardy–Weinberg Equilibrium in the Case of a Biallelic Locus

  2004cited by this paper
• Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted.

  2004cited by this paper
• Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

  2004cited by this paper
• ADVANCES IN TWIN AND SIB-PAIR ANALYSIS

  2004cited by this paper
• Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity

  2004cited by this paper
• Pharmacogenetics of Nicotine Metabolism in Twins: Methods and Procedures

  2004cited by this paper
• Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.

  2004cited by this paper
• Effects of polymorphism in Promoter Region of Human CYP2A6 Gene (CYP2A6*9) on Expression Level of Messenger Ribonucleic Acid and Enzymatic Activity In Vivo and In Vitro

  2003cited by this paper
• Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9).

  2003cited by this paper
• Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity

  2002cited by this paper
• CYP2A6 genetic variation and potential consequences.

  2002cited by this paper
• Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: impairment of its promoter activity.

  2001cited by this paper
• Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism.

  2001cited by this paper
• Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.

  2000cited by this paper
• Generalisability and assumptions of twin studies

  2000cited by this paper
• Nicotine metabolism and intake in black and white smokers.

  1998cited by this paper
• A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes.

  1997cited by this paper
• Role of human cytochrome P4502A6 in C-oxidation of nicotine.

  1996cited by this paper
• Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.

  1996cited by this paper
• Metabolism of nicotine to cotinine studied by a dual stable isotope method

  1994cited by this paper
• Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine.

  1994cited by this paper
• Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers

  1993cited by this paper
• Determination of the nicotine metabolite trans-3'-hydroxycotinine in urine of smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring.

  1992cited by this paper
• Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.

  1991cited by this paper
• Synthesis of optically pure deuterium‐labelled nicotine, nornicotine and cotinine

  1988cited by this paper
• Determinants of nicotine intake while chewing nicotine polacrilex gum

  1987cited by this paper

• Inhibitory effects of Δ8-tetrahydrocannabinol on nicotine metabolism and implications as a smoking cessation agent

  2026cites this paper
• Pharmacokinetic Evaluation of a Cinnamon Product on CYP2A6 Substrate Drugs: Application of a Novel Tool Involving the Nicotine Metabolite Ratio.

  2026cites this paper
• Nicotine promotes AngII-induced abdominal aortic aortopathies in female and male mice: role of sex hormones

  2025cites this paper
• A Randomized Crossover Clinical Study to Assess the Effect of Oral Nicotine Pouches Used for Different Durations on Plasma Nicotine Pharmacokinetics in Healthy Oral Pouch Consumers

  2025cites this paper
• Development of a Physiologically Based Pharmacokinetic (PBPK) Simulation Model for Nicotine

  2025cites this paper
• Inhibition of CYP2A6-mediated nicotine metabolism: A potential strategy for smoking cessation therapy.

  2025cites this paper
• Abuse Liability Assessment of the RELX Infinity® Electronic Nicotine Delivery System Among Adult Smokers and Electronic Nicotine Delivery System Users

  2025cites this paper
• Randomized crossover clinical studies to assess abuse liability and nicotine pharmacokinetics of Velo Oral Nicotine pouches

  2025cites this paper
• A quantitative comparison of the deleteriousness of missense and nonsense mutations using the structurally resolved human protein interactome

  2025cites this paper
• Pharmacokinetic Analysis of Nicotine and Its Metabolites (Cotinine and trans-3'-Hydroxycotinine) in Male Sprague-Dawley Rats Following Nose-Only Inhalation, Oral Gavage, and Intravenous Infusion of Nicotine.

  2024cites this paper
• The "double-edged sword effect" of nicotine.

  2024cites this paper
• The impact of rate of nicotine metabolism, as measured by the nicotine metabolite ratio (NMR), on smoking behaviours during pregnancy: A scoping review

  2024cites this paper
• Age‐Dependent Abundance of CYP450 Enzymes Involved in Metronidazole Metabolism: Application to Pediatric PBPK Modeling

  2024cites this paper
• Disentangling the effects of nicotine versus non‐nicotine constituents of tobacco smoke on major depressive disorder: A multivariable Mendelian randomisation study

  2024cites this paper
• Part two: an unblinded, parallel, randomized study to assess nicotine pharmacokinetics of four Vuse Solo ENDS flavors in smokers

  2023cites this paper
• Maternal nicotine metabolism moderates the impact of maternal cigarette smoking on infant birth weight: A Collaborative Perinatal Project investigation.

  2022cites this paper
• Tobacco and nicotine use

  2022cites this paper
• CYP2C19 Plays a Major Role in the Hepatic N-Oxidation of Cotinine

  2022cites this paper
• Hand nicotine as an independent marker of thirdhand smoke pollution in children’s environments

  2022influential citation
• "Genetic influences impacting nicotine use and abuse during adolescence: insights from human and rodent studies".

  2022cites this paper
• Nicotine addiction – a health problem in adolescents in a neurobiological context

  2022cites this paper
• Differential associations of hand nicotine and urinary cotinine with children's exposure to tobacco smoke and clinical outcomes.

  2021cites this paper
• Polymorphism in cytochrome P4502A6 reduces the risk to head and neck cancer and modifies the treatment outcome

  2021cites this paper
• Nicotine Addiction: Translational Insights from Circuit Neuroscience.

  2021cites this paper
• High Glucose Restraint of Acetylcholine-Induced Keratinocyte Epithelial-Mesenchymal Transition Is Mitigated by p38 Inhibition

  2021influential citation
• DNA methylation differentiates smoking from vaping and non-combustible tobacco use

  2021cites this paper
• Nicotine metabolism predicted by CYP2A6 genotypes in relation to smoking cessation: A systematic review.

  2021cites this paper
• A genome-wide association study of quantitative computed tomographic emphysema in Korean populations

  2021cites this paper
• Pharmacogenetic Variation in Neanderthals and Denisovans and Implications for Human Health and Response to Medications

  2021cites this paper
• Comparison of Levels of Three Tobacco Smoke Exposure Biomarkers in Children of Smokers

  2021cites this paper
• Full title: Association of the Time to First Cigarette and the Prevalence of Chronic Respiratory Diseases in Chinese Elderly Population Short title: Time to First Cigarette and Respiratory Disease

  2021cites this paper
• Title : Archaic introgression and variation in pharmacogenes and implications for local adaptation

  2021cites this paper
• Genetic Polymorphism of Cyp2a6 and Cyp2a13 Genes and Environmental Tobacco Smoke Induced Lung Cancer Risk in Indonesian Female Never Smokers

  2021cites this paper
• Biochemistry of nicotine metabolism and its relevance to lung cancer

  2021cites this paper
• Multifactorial Etiology of Adolescent Nicotine Addiction: A Review of the Neurobiology of Nicotine Addiction and Its Implications for Smoking Cessation Pharmacotherapy

  2021cites this paper
• Association of the Time to First Cigarette and the Prevalence of Chronic Respiratory Diseases in Chinese Elderly Population

  2021cites this paper
• Not all smokers are alike: the hidden cost of sustained attention during nicotine abstinence

  2021cites this paper
• Promotion and Chronic Disease Prevention in Canada Research, Policy and Practice

  2020cites this paper
• Association between CYP2A6 genotypes and smoking behavior in Lebanese smokers

  2020cites this paper
• Tobacco smoke exposure and sleep: estimating the association of urinary cotinine with sleep quality.

  2020cites this paper
• Epigenetic Profiling of Obesity and Smoking

  2020cites this paper
• Opioid and neuroHIV Comorbidity – Current and Future Perspectives

  2020cites this paper
• High glucose restrains acetylcholine-induced keratinocyte EMT is mitigated by p38 inhibition.

  2020cites this paper
• Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation

  2020cites this paper
• An active site mutation in 6-hydroxy-l-Nicotine oxidase from Arthrobacter nicotinovorans changes the substrate specificity in favor of (S)-nicotine.

  2020cites this paper
• Exposition à la fumée du tabac et sommeil : estimation de l’association entre concentration de cotinine urinaire et qualité du sommeil

  2020cites this paper
• IMPACT OF E-CIGARETTE LIQUID FLAVORING AGENTS ON ACTIVITY OF MICROSOMAL RECOMBINANT CYP2A6, THE PRIMARY NICOTINE-METABOLIZING-ENZYME.

  2020cites this paper
• Use of a physiologically-based pharmacokinetic model to explore the potential disparity in nicotine disposition between adult and adolescent nonhuman primates.

  2019cites this paper
• Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults

  2019cites this paper
• Use of the Fagerström test to assess differences in the degree of nicotine dependence in smokers from five ethnic groups: The HELIUS study.

  2019cites this paper
• Relationship between skin melanin index and nicotine pharmacokinetics in African American smokers.

  2019cites this paper
• Not all smokers appear to seek nicotine for the same reasons: implications for preclinical research in nicotine dependence

  2019cites this paper
• Pharmacogenetics and Smoking Cessation

  2019cites this paper
• Urine Metabolites for Estimating Daily Intake of Nicotine from Cigarette Smoking.

  2019cites this paper
• Associations of CYP2A6 Gene Polymorphism with Smoking Status among Jordanians: Gender-Related Differences.

  2019cites this paper
• Pharmacogenomics of nicotine metabolism: novel CYP2A6 and CYP2B6 genetic variation patterns in Alaska Native and American Indian populations.

  2019cites this paper
• Genetically determined metabolism of nicotine and its clinical significance.

  2019influential citation
• Nicotine Pharmacokinetics in Rat Brain and Blood by Simultaneous Microdialysis, Stable-Isotope Labeling, and UHPLC-HRMS: Determination of Nicotine Metabolites.

  2019cites this paper
• P450 Pharmacogenetics in Indigenous North American Populations

  2018cites this paper
• Assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum

  2018cites this paper
• Biosignature Discovery for Substance Use Disorders Using Statistical Learning.

  2018cites this paper
• Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real‐world settings? A prospective study

  2018cites this paper
• Neurogenetic determinants and mechanisms of addiction to nicotine and smoked tobacco

  2018cites this paper
• Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers

  2018cites this paper
• Management, Pharmacotherapies, and Precision Medicine for Smoking Cessation

  2018cites this paper
• Nicotine metabolite ratio and smoking outcomes using nicotine replacement therapy and varenicline among smokers with and without psychiatric illness

  2018cites this paper
• Genome‐wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences

  2018cites this paper
• Role of CYP2B6 pharmacogenomics in bupropion‐mediated smoking cessation

  2018cites this paper
• Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human Urine

  2018cites this paper
• Cytochrome P450s and Alcoholic Liver Disease.

  2018cites this paper
• Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.

  2017cites this paper
• Pharmacogenetic Optimization of Smoking Cessation Treatment.

  2017cites this paper
• CYP2A6 Genetic Variation Alters Striatal-Cingulate Circuits, Network Hubs, and Executive Processing in Smokers.

  2017influential citation
• Alcoholic Liver Disease: from CYP2E1 to CYP2A5.

  2017cites this paper
• Association of Nicotine Metabolism and Sex With Relapse Following Varenicline and Nicotine Replacement Therapy

  2017cites this paper
• Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis

  2017cites this paper
• Evaluating the Real-World Effectiveness of Bupropion Versus Varenicline for Smoking Cessation: Exploring the Role of Nicotine Metabolism and Medication Adherence

  2017cites this paper
• Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans

  2017cites this paper
• 12 Using Ontologies in Hierarchical Modeling of Genes and Exposure in Biological Pathways

  2017cites this paper
• CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study

  2017cites this paper
• Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction

  2017influential citation
• 2 Status of Genetic Studies of Nicotine Dependence

  2017cites this paper
• Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.

  2017cites this paper
• Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability

  2017cites this paper
• CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.

  2016cites this paper
• Meta‐analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling

  2016cites this paper
• Sources of Variation in Nicotine Metabolism and Associations with Smoking Abstinence in Adolescents and Adults

  2016cites this paper
• Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior.

  2016cites this paper
• Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.

  2016cites this paper
• Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity

  2016cites this paper
• Genetic Aspects of Smoking Behavior in the Japanese Population

  2016cites this paper
• Smokescreen: a targeted genotyping array for addiction research

  2016cites this paper
• Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio

  2016cites this paper
• Impact of the interactions of CYP2B6*6 and CYP2A6 Polymorphisms on the treatment of nicotine dependence

  2016influential citation
• Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.

  2016cites this paper
• Neurobiology of addiction: a neurocircuitry analysis.

  2016cites this paper
• Genetic Risk Determinants for Cigarette Smoking Dependence in Mexican Mestizo Families.

  2016cites this paper
• Alcohol Upregulation of CYP2A5: Role of Reactive Oxygen Species.

  2016cites this paper
• Effectiveness of Standard vs Individualized Treatment on Smoking Cessation and Cue Reactivity: An fMRI Study

  2016cites this paper
• Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study

  2016influential citation